Source: Annual Congress 2012 - Cell culture and animal models of lung disease
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
T. Müller, A. Hüttel, M. Grimm, M. Idzko (Freiburg, Germany). The serotoninergic receptor subtype 5-HTR1B contributes to the pathogenesis of allergic airway inflammation. Eur Respir J 2012; 40: Suppl. 56, 3740

Member's Comments

No comment yet.

Related content which might interest you: Cholinergic muscarinic receptors and airway remodelling in severe asthma Source: International Congress 2018 – Studies on the mechanisms underlying airway disease Year: 2018 Role of muscarinic receptors in airway inflammation and remodelling Source: International Congress 2015 – Respiratory research in the Netherlands Year: 2015 A decreased expression of leptin receptor may contribute to the pathogenesis of the allergic rhinitis Source: Annual Congress 2010 - Asthma: clinical aspects and treatment Year: 2010 Protease-activated receptor 1 activation exaggerates allergic airway inflammation in mice Source: Annual Congress 2008 - Understanding allergic airway inflammation with the help of animal models Year: 2008 A fully dissociated glucocorticoid receptor modulator reduces airway hyperresponsiveness and inflammation in a murine model of asthma Source: Annual Congress 2010 - Pre-clinical models of airways disease Year: 2010 The muscarinic M3 receptor regulates allergen-induced airway remodeling in mice Source: Annual Congress 2013 –Asthma drugs: new findings Year: 2013 The role of purinergic P2X7 receptors on lipopolysaccharide (LPS)-induced lung injury Source: Annual Congress 2007 - Acute and chronic lung injury and its repair: novel molecular insight Year: 2007 Involvement of NK1, 2 and 3 receptors on antigen-induced airway hyperresponsiveness and inflammation induced in guinea-pigs Source: Eur Respir J 2001; 18: Suppl. 33, 246s Year: 2001 Effect of muscarinic receptors inhibition on cytokine release and inflammatory cells infiltration in the airway of cat as an animal model for COPD Source: Annual Congress 2012 - Animal models of asthma and COPD and late-breaking abstracts on RCT in asthma and COPD Year: 2012 Airway hyperresponsiveness in offspring from mothers with allergic airway inflammation during pregnancy is muscarinic receptor and ADAM33 dependent. Source: Virtual Congress 2020 – Novel molecular markers and targets for asthma phenotypes Year: 2020 The pathway to inflammation in asthma: the role of the DP2 receptor Source: International Congress 2019 – The journey towards personalized medicine in asthma: where are we now? Year: 2019 The role of lipoxin A4 and its receptor in pathogenesis of inflammatory lung diseases Source: Annual Congress 2010 - Novel markers of lung injury Year: 2010 Role of airway smooth muscles in chronic airway inflammation and lung fibrosis and possible therapeutic potential of endothelin receptor antagonism Source: Annual Congress 2010 - New mechanisms in lung development, acute and chronic lung diseases Year: 2010 Comparison of glucocorticoid and cysteinyl leukotriene receptor antagonist treatments in the airway remodeling induced by chronic airway inflammation in guinea pigs Source: Annual Congress 2008 - Novel experimental approaches to understanding asthma and COPD II Year: 2008 IL-33 blockade impacts mediators of persistence and exacerbation of chronic airway inflammation. Source: International Congress 2018 – Novel drug targets for asthma and COPD Year: 2018 Changes in muscarinic cholinergic receptor expression in human peripheral blood lymphocytes in allergic rhinitis patients Source: Eur Respir J 2006; 28: Suppl. 50, 748s Year: 2006 Cholinergic synapse pathway gene polymorphisms associated with allergen-induced late asthmatic responses Source: ERJ Open Res, 5 (4) 00107-2019; 10.1183/23120541.00107-2019 Year: 2019 Interaction of the glutamatergic and nitrergic signaling system in the airway hyperreactivity Source: Annual Congress 2012 - Animal models of asthma and COPD and late-breaking abstracts on RCT in asthma and COPD Year: 2012 EP2 & EP4 receptor agonists inhibit the airway sensory nerves that cause cough, a potential protective control that is lost in human smokers and a pre-clinical COPD model Source: International Congress 2017 – Novel mechanisms and treatments for COPD Year: 2017 Absence of proton-sensing TDAG8 protects against ovalbumin-induced allergic airway inflammation Source: International Congress 2017 – New insights into pathogenesis of lung disease  Year: 2017